Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On March 18, 2021, Inotiv, Inc. (the "Company") filed Articles of Amendment to its Second Amended and Restated Articles of Incorporation, as amended (the "Articles"), reflecting its corporate name change from Bioanalytical Systems, Inc. to Inotiv, Inc., effective on March 18, 2021. In addition, on March 18, 2021, the Company revised its Second Amended and Restated Bylaws, as amended (the "Bylaws"), to reflect its corporate name change.

This summary is qualified in its entirety by reference to the Articles and Bylaws, copies of which are attached hereto as Exhibit 3.1 and Exhibit 3.2, respectively, and are incorporated here by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders

On March 18, 2021, the Company held its annual meeting of shareholders. A total of 8,378,513 shares of the Company's common stock outstanding and entitled to vote were present at the meeting in person or by proxy. The following is a summary of matters voted on at the meeting:

a. Two Class III members of the Board of Directors were elected to serve a


    three-year term ending in 2024 with the following votes cast:




      Nominee                                  For   Withheld   Broker Non-Vote
      Gregory C. Davis, Ph.D.            5,488,294    697,021         2,193,198
      John E. Sagartz, DVM, PhD, DACVP   5,523,647    661,668         2,193,198

b. The appointment of RSM US LLP as our independent registered public accountants


    for fiscal 2021 was ratified by the following shareholder vote:




                              Vote Type       Voted
                              For         7,715,194
                              Against         3,169
                              Abstain       660,150

c. The proposal to approve the filing of Articles of Amendment to the Company's


    Second Amended and Restated Articles of Incorporation, as amended, in order to
    change our corporate name to Inotiv, Inc., passed with the following votes
    cast:




                              Vote Type       Voted
                              For         8,224,039
                              Against       126,578
                              Abstain        27,896

Item 7.01 Regulation FD Disclosure.

On March 19, 2021, the Company issued the attached press release regarding the Company's corporate name change to Inotiv, Inc. The information furnished under Item 7.01 of this Current Report on Form 8-K and in Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.   Description
  3.1           Second Amended and Restated Articles of Incorporation of Inotiv,
              Inc. (formerly known as Bioanalytical Systems, Inc.), as amended
              through March 18, 2021
  3.2           Second Amended and Restated Bylaws of Inotiv, Inc. (formerly known
              as Bioanalytical Systems, Inc.), as amended through March 18, 2021
  99.1          Press Release, dated March 19, 2021.

© Edgar Online, source Glimpses